STOCKS IN ACTION 7 November

Cipla: The drugmaker approved the transfer of the generics business to the unit Cipla Pharma and Life Sciences. The generics business will be transferred for a consideration of Rs 350 crore. The sale will be completed by Dec. 31, 2023.

Bajaj Finance: The company opened QIP on Nov. 6, 2023, with a floor price set at Rs 7,533.81 per equity share. The floor price is at a discount of 0.37% to the stock's closing price of Rs 7,562.05 on Monday

K.P.R. Mill: The company approved an investment of Rs 250 crore for the expansion of fabric processing capacity. Fabric processing capacity is set to increase from 25,000 MT to 37,000 MT per year. It also approved an investment of Rs 100 crore to increase solar power generation capacity to 37 MW.

Central Bank of India: Ministry of Finance extended MV Rao's term as MD and CEO till July 31, 2025, from the current notified term ending on Nov. 29, 2024.

Quess Corp: The company approved buying a 4.5% stake in Vedang Cellular Services from the promoter for Rs 6.05 crore, increasing its total stake to 96.97%. The board also approved the acquisition of an additional 46.09% stake in unit Stellarslog Technovation for Rs 6.8 crore, increasing its total stake to 100%.

EICHERMOTORS: Royal Enfield Himalayan 452 Launch

SPECIALITY RESTAURANTS:
Boardmeet To Consider Allotment of Shares on conversion of warrants

DILIP BUILDCON: Boardmeet
To Consider Fund Raising Proposal

ATUL LTD: Boardmeet To Consider Buy-Back of Equity Shares

INOX WIND: Boardmeet
To Consider Fund Raising Proposal

CELLO WORLD:
LARGE TRADE PLUTUS WEALTH MANAGEMENT LLP
Buy 12,50,000 Shares @ Rs 801.81/ Share
RELIANCE COMMERCIAL FINANCE LIMITED
Buy 16,00,060 Shares @ Rs 794.2/ Share

STRIDES PHARMA SCIENCE:
LARGE TRADE BNP Paribas Arbitrage Buy 9.49 Lakh Shares @ Rs 470/ Share
Promoter Entity Pronomz Ventures Sold The Chunk

@daytradertelugu